Transplant News and Research RSS Feed - Transplant News and Research

JINARC (tolvaptan) accepted for use in Scotland for ADPKD treatment

JINARC (tolvaptan) accepted for use in Scotland for ADPKD treatment

From today, people in Scotland with the genetic kidney disease ADPKD could benefit from JINARC® (tolvaptan) following advice issued by the Scottish Medicines Consortium (SMC) for its use in adults with chronic kidney disease (CKD) stages 1-3 at the start of treatment with evidence of rapidly progressing disease. [More]
Using skin cells to treat injured hearts

Using skin cells to treat injured hearts

Following a heart attack or other heart trauma, the heart is unable to replace its dead cells. Patients are often left with little option other than heart transplants, which are rarely available, or more recently cell therapies that transplant heart cells into the patient's heart. In far too many cases, however, the transplanted heart cells do not engraft well, resulting in poor recovery. [More]
MiMedx Group agrees to buy Stability Biologics

MiMedx Group agrees to buy Stability Biologics

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry. [More]
Anthony Nolan introduces new tissue typing method that could revolutionise stem cell transplantation

Anthony Nolan introduces new tissue typing method that could revolutionise stem cell transplantation

Anthony Nolan has today launched a new tissue typing method that could significantly improve stem cell transplant outcomes. [More]
ISHLT issues new list of criteria to determine patient eligibility for heart transplant

ISHLT issues new list of criteria to determine patient eligibility for heart transplant

To determine patient eligibility for heart transplant, the International Society for Heart Lung Transplantation maintains a list of criteria, first issued in 2006, that acts as a guideline for physicians. [More]
Scientists find genetic link to unexplained heart failure affecting pregnant women

Scientists find genetic link to unexplained heart failure affecting pregnant women

Scientists have found that women who suffer unexplained heart failure towards the end of pregnancy or shortly after giving birth share certain genetic changes. [More]
New allocation system boosts kidney transplantation rates for black and Hispanic patients on waiting lists

New allocation system boosts kidney transplantation rates for black and Hispanic patients on waiting lists

Year-old changes to the system that distributes deceased donor kidneys nationwide have significantly boosted transplantation rates for black and Hispanic patients on waiting lists, reducing racial disparities inherent in the previous allocation formula used for decades, according to results of research led by a Johns Hopkins transplant surgeon. [More]
MUSC researchers awarded NIH grant to study use of technology for kidney transplant patients

MUSC researchers awarded NIH grant to study use of technology for kidney transplant patients

A group of MUSC researchers in the College of Medicine's Department of Surgery and the College of Nursing has been awarded a $1.11 million National Institutes of Health grant to examine a novel use of mobile health technology to reduce kidney transplant recipient premature graft loss. [More]
Antibiotic prophylaxis may be recommended for dental patients

Antibiotic prophylaxis may be recommended for dental patients

When the majority of patients go in for their dental visits there is not much of a risk for bacterial infection. But for a small number of people, the use of antibiotic prophylaxis may be recommended by your dentist. [More]
Discovery Life's new unscripted docudrama series highlights lifesaving work by SOM and Shock Trauma caregivers

Discovery Life's new unscripted docudrama series highlights lifesaving work by SOM and Shock Trauma caregivers

Discovery Life's new unscripted docudrama series Shock Trauma: Edge of Life follows a team of medical professionals at the world-renown R Adams Cowley Shock Trauma Center, University of Maryland ("Shock Trauma"). [More]
Microencapsulation method can help overcome challenges in pancreatic islet transplantation

Microencapsulation method can help overcome challenges in pancreatic islet transplantation

A microencapsulation method, developed by OIST researchers, can help to overcome major challenges in pancreatic islet transplantation. [More]

AeroCare Medical Transport System announces opening of new base of operations in Ft. Lauderdale

AeroCare Medical Transport System, Inc. has opened a new base of operations in Ft. Lauderdale, FL. The base opened in December 2015 and is located at the Ft. Lauderdale Executive Airport (FXE). [More]
SCCA's Fred Hutch Bone Marrow Transplant Program recognized for outstanding survival rates

SCCA's Fred Hutch Bone Marrow Transplant Program recognized for outstanding survival rates

The Fred Hutch Bone Marrow Transplant Program at Seattle Cancer Care Alliance has earned recognition by the Center for International Blood and Marrow Transplant Research for outperforming its expected one-year survival rates for allogeneic transplant patients - those who receive donated adult blood-forming stem cells. [More]
Department of Health issues statement on CDC preliminary report regarding infection cluster at UPMC

Department of Health issues statement on CDC preliminary report regarding infection cluster at UPMC

Today, Pennsylvania Secretary of Health Karen Murphy issued a statement on the Centers for Disease Control (CDC) preliminary report on an infection cluster found at the University of Pittsburgh Medical Center (UPMC). [More]
Prevalence of chronic kidney disease considerably varies across Europe

Prevalence of chronic kidney disease considerably varies across Europe

The first study to carefully characterize the prevalence of chronic kidney disease (CKD) across Europe found considerable variation. The findings appear in an upcoming issue of the Journal of the American Society of Nephrology. [More]
Variant signs worldwide exclusive license and development agreement with L&F Research

Variant signs worldwide exclusive license and development agreement with L&F Research

Variant Pharmaceuticals, Inc., an emerging pharmaceutical company focusing on rare diseases and other specialty conditions with limited or sub-optimal therapeutic options, announced today a worldwide exclusive license and development agreement with L&F Research LLC to advance development of Variant's lead product, VAR 200. [More]
Mayo Clinic study shows link between frailty and survival after lung transplant procedure

Mayo Clinic study shows link between frailty and survival after lung transplant procedure

Frailty can affect people of all ages and demographics. Defined simply as "an increased vulnerability to adverse health outcomes," frailty can affect a patient's chances of surviving a surgical procedure or needing a nursing home. [More]
Anti-aging Glycopeptide can improve efficacy of cell transplant treatments for diabetes patients

Anti-aging Glycopeptide can improve efficacy of cell transplant treatments for diabetes patients

An antifreeze glycopeptide that mimics a naturally occurring glycoprotein found in Arctic fish is helping to significantly improve the efficacy of cell transplant treatments for diabetes patients--a procedure that transplants insulin producing islets to render them insulin independent for periods of time. [More]
Stem cell therapy not significantly better than conventional treatment for Crohn's disease

Stem cell therapy not significantly better than conventional treatment for Crohn's disease

A clinical trial to test the effectiveness of a stem cell therapy among adults with difficult to treat Crohn's disease has found it is not significantly better than conventional treatment in producing sustained disease remission after one year. [More]
CRCHUM researchers find mechanism responsible for rejection of organ transplants

CRCHUM researchers find mechanism responsible for rejection of organ transplants

A new cellular structure responsible for previously unexplained rejection of organ transplants has been identified by researchers at the University of Montreal Hospital Research Centre. [More]
Advertisement
Advertisement